Plains All American Pipeline LP Reports $672M Adjusted EBITDA in 2Q25, Exceeds Full-Year Guidance Expectations

Reuters
2025/08/08
<a href="https://laohu8.com/S/PAAPU">Plains All American Pipeline</a> LP Reports $672M Adjusted EBITDA in 2Q25, Exceeds Full-Year Guidance Expectations

Plains All American Pipeline LP reported its second-quarter 2025 results, highlighting a solid execution and continued progress on strategic initiatives. The company achieved an adjusted EBITDA attributable to PAA of $672 million. Specifically, the crude and NGL segments contributed $580 million and $87 million, respectively, to the adjusted EBITDA. The company has also provided full-year guidance for adjusted EBITDA attributable to PAA, which is estimated to be between $2.80 billion and $2.65 billion. The leverage ratio for the second quarter stood at 3.3x, indicating significant financial flexibility. In terms of operational updates, Plains All American Pipeline LP completed a divestiture of its NGL business, valued at approximately $3.75 billion, resulting in net proceeds of around $3 billion after taxes and transaction expenses. This transaction is set to improve cash flow durability and enhance financial flexibility by reducing commodity exposure and working capital needs. Additionally, the company has acquired an additional interest in the BridgeTex Pipeline, now owning a 40% stake, which is expected to contribute further to its growth and optimization efforts.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Plains All American Pipeline LP published the original content used to generate this news brief on August 08, 2025, and is solely responsible for the information contained therein.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10